Trastuzumab Deruxtecan in a Patient with Breast Cancer on Hemodialysis: a Case Report-Reference-Cited by-同舟云学术

Trastuzumab Deruxtecan in a Patient with Breast Cancer on Hemodialysis: a Case Report

Published:2022-07-10 Issue:7 Volume:48 Page:284-291
ISSN:1346-342X
Container-title:Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
language:en
Short-container-title:Jpn. J. Pharm. Health Care Sci.

Author:

Suehiro Marii¹,Kojima Yasuyuki²,Kobayashi Ayako¹,Yokomizo Ayako¹,Minatogawa Hiroko¹,Tanaka Tsuneaki¹

Affiliation:

1. Department of Pharmacy, St. Marianna University School of Medicine Hospital

2. Division of Breast and Endocrine Surgery, Department of Surgery, St. Marianna University School of Medicine Hospital

Publisher

Japanese Society of Pharmaceutical Health Care and Sciences

Subject

General Engineering

Link

https://www.jstage.jst.go.jp/article/jjphcs/48/7/48_284/_pdf

Reference24 articles.

1. 1）国立がん研究センターがん情報サービス「がん統計」（厚生労働省人口動態統計）．

2. 2）国立がん研究センターがん情報サービス「がん統計」（全国がん登録）．

3. 3）全国がん罹患モニタリング集計　2009-2011年生存率報告（国立研究開発法人国立がん研究センターがん対策情報センター, 2020）2009-2011年診断例の5年相対生存率　－臨床進行度別, 男女計－．

4. 4）日本乳癌学会編, “乳癌診療ガイドライン 2018年版［追補2019］”, 金原出版, 東京, 2019．

5. 5）National Comprehensive Cancer Network (NCCN), Clinical Practice Guidelines in Oncology (NCCN Guidelines^®), Breast Cancer, Version 2, 2022. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf, Published December 20, 2021, 2022年2月8日.